Before coming to UMass Medical School's New England Newborn Screening Program in 1991, Dr. Roger Eaton specialized in microbiology and immunology in the academic research environment of Harvard Medical School. His initial focus at UMass Medical School was the congenital toxoplasmosis screening program, which is unique to this program. Director since 1998, Dr. Eaton is responsible for all administrative, regulatory, and policy aspects of the program. Under his direction, the faculty and technical team was among the first in the country to apply tandem mass spectrometry to state-regulated newborn screening in 1999, succinylacetone screening in 2008, and screening for severe combined immunodeficiency in 2009.
Eaton is a member of the Association of Public Health Laboratories (APHL) and the International Society of Newborn Screening. He has served on a number of national and international workgroups, including the APHL's Steering Committee for the Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) and Health Information Technology Workgroup; the Program Evaluation and Assessment Scheme (HRSA); the European-based SYROCOT study group on toxoplasmosis; the Health Information Technology Workgroup for the U.S. Secretary of Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children; the National Coordinating Center for the Genetics and Newborn Screening Regional Collaborative Groups Emergency Preparedness Workgroup; and the Newborn Screening Translational Research Network Laboratory Workgroup. In these national workgroup memberships, Eaton has been an invited expert at a number of national stakeholders meetings, on such topics as Immunoreactive Trypsinogen testing, G6PD screening, Continuity of Operations Planning for national disasters affecting newborn screening, and electronic transmission of newborn screening hemoglobin results.
Eaton serves on several regional advisory boards, and also has been principal investigator on a three-year HRSA grant (Multicenter Validation of Algorithms to Improve Communications of Positive Newborn Screening Results to the Medical Home), as well as a project leader on additional federal grants.
Eaton received his master’s and doctorate degrees from the State University of New York, and did his postdoctoral fellowship at Harvard Medical School. He received his bachelor’s degree from the University of Vermont.
Learn more about Dr. Eaton's academic work.